News & Updates

Patients with atrial fibrillation receiving a reduced dose of direct acting oral anticoagulants (DOAC), particularly rivaroxaban and dabigatran, show a similar incidence of ischaemic stroke and systemic embolism to those receiving warfarin, a study has shown.

High cognitive reserve appears to confer protection against dementia, even among people with genetic predisposition to dementia, according to a study.

A long-term study showed that individuals who have recovered from COVID-19 continued to experience cognitive, psychiatric, and neurological issues, as well as brain functional alteration, even 2 years after being infected.

A dietary pattern intervention may offer some help in reducing the symptoms of Parkinson’s disease (PD), including both motor and nonmotor symptoms, reports a study.

Having an orthostatic hypotension (OH) appears to promote the development of dementia in type 2 diabetes mellitus (T2DM) patients with mild cognitive impairment (MCI), suggests a study.

New local findings presented at HKMF 2024 show an increasing trend in intracerebral haemorrhage (ICH) among patients on direct oral anticoagulants (DOACs) between 2013 and 2022. Early initiation of reversal agents may improve outcomes in select cases with DOAC-related ICH.